Universal preoperative SARS-CoV-2 testing can facilitate safe surgical treatment during local COVID-19 surges.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 33640925.
- Also identified by DOI 10.1093/bjs/znaa062 and PMC identifier 7799208.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This research letter details the experience of a large cancer center's experience with a universal asymptomatic preoperative SARS-CoV-2 testing program that facilitated safe surgical treatment during a local surge of coronavirus cases. A total of 5,234 asymptomatic tests were performed with a test positivity rate that correlated with the increase in community prevalence of COVID-19 infections. No patients developed a postoperative SARS-CoV-2 infection with no documented patient-to-patient or patient-to-provider spread.
Medical subject headings
- COVID-19
- COVID-19 Testing
- Elective Surgical Procedures
- Preoperative Care